Please login to the form below
Hal Barron
This page shows the latest Hal Barron news and features for those working in and with pharma, biotech and healthcare.
GSK appoint Tony Wood as chief scientific officer
Wood’s appointment will follow the exit of Dr Hal Barron, effective from August 2022. ... Wood will succeed Dr Hal Barron as CSO. Barron will continue to serve as a board member on GSK’s Science Committee for an initial three-year period.
Latest news
-
GSK/Merck KGgA cancer drug fails in third trial
chief, Hal Barron.
-
GlaxoSmithKline agrees $2.2bn dementia mAb deal with Alector
neurodegenerative diseases,” said Hal Barron (pictured right), chief scientific officer and president R&D, GSK.
-
GSK partners with iTeos Therapeutics on next-gen immuno-oncology drug
Immuno-oncology has transformed cancer care but unfortunately less than 30% of patients respond to treatment with the current leading immune checkpoint inhibitors,” said Hal Barron, chief scientific officer and president
-
GSK, Vir’s COVID-19 mAb scores FDA emergency use approval
Hal Barron, chief scientific officer and president R&D at GSK.
-
GSK wins approval for anti-PD-1 antibody Jemperli in endometrial cancer
after first-line therapy,” said Hal Barron, chief scientific officer and president of R&D at GSK.
More from news
Approximately 2 fully matching, plus 56 partially matching documents found.
Latest Intelligence
-
30 Women Leaders in UK Healthcare (part 3)
Walmsley has impressed with a few high-profile hirings to key positions, including Dr Hal Barron as its new R&D supremo, but it will take a few years to see
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Kevin Sin joins GSK
years. Dr Hal Barron, chief scientific officer and president of research and development, GSK, said: “I am extremely excited to have Kevin join GSK. ... Sin will report to Hal Barron and will be based at the group’s San Francisco office.
-
Levinson resigns from Roche board
He has served as CEO at Calico, Google's health research business, since its formation in September 2013 and has since been joined by former Genentech/Roche colleagues Hal Barron, David
-
Roche CMO joins Google health venture Calico
Hal Barron among four new appointments. Dr Hal Barron has left his role as chief medical officer of Swiss pharma company Roche to join Google's recently-launched health research arm ... Dr Barron is one of four new recruits from industry and academia to
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
Wiley
Wiley is a global leader in research and education. We clear the path for seekers of knowledge, leading the way...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
